Market Status
Innovative new drugs with high treatment rate (First in Class) and cheaper new drugs (Best in Class ) It is the vision and goal that anyone can receive treatment through the development of CAR-T cell therapy .
Although CAR-T cell therapy has a high treatment rate, it is difficult for patients to receive treatment with the most expensive anticancer drug among existing anticancer drugs.
Currently, research and investment in cell therapy are increasing, and with active research progress, Sales are also increasing thanks to the rapid product launch.
Currently, the amended legislation enables rapid commercialization and commercialization.
In accordance with these market trends, CAR-T cell therapy research is being conducted, and the amended legislation enables rapid commercialization, aiming to rapidly expand treatment opportunities for patients.